NEOG insider filings
NEOGEN CORP — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-04. Screen NEOG transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 24 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 1 insider — 505 shares, $6,035 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 9,051 shares, $114,676 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 9,051 shares @ $12.67 ($114,676) by Yarwood Jeremy, filed 2026-11-04.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Yarwood Jeremy — Chief Scientific Officer | 2 | — | 1 leg · 9,051 sh · $114,676 | 2 |
| Nassif Mikheal — CEO, Director | 1 | 1 leg · 505 sh · $6,035 | — | — |
| Hastings Gregory S — VP, Animal Health | 3 | — | — | 6 |
| BOREL JAMES C — Director | 2 | — | — | 4 |
| CAPELLO JEFFREY D — Director | 2 | — | — | 4 |
| Green Ronald D — Director | 2 | — | — | 4 |
| Gupta Aashima — Director | 2 | — | — | 4 |
| RODRIGUEZ RAFAEL A — Director | 2 | — | — | 4 |
| Woteki Catherine E — Director | 2 | — | — | 4 |
| Freels Joe B — Chief Commercial Officer | 2 | — | — | 2 |
+4 more insiders in the window, not shown — every filing appears in the table below.
Recent insider filings — NEOGEN CORP
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Yarwood Jeremy — Chief Scientific Officer | Option exercise (M): 16,207 @ $11.82 · Tax withholding (F): 7,156 @ $11.82 · Sale (S): 9,051 @ $12.67 | EDGAR |
| 2026-11-03 | 4 | Freels Joe B — Chief Commercial Officer | Grant/award (A): 6,345 @ $11.82 · Grant/award (A): 31,311 (derivative) @ $0 | EDGAR |
| 2026-10-30 | 4 | Hastings Gregory S — VP, Animal Health | Option exercise (M): 1,211 @ $12.21 · Tax withholding (F): 337 @ $12.21 · Option exercise (M): 1,211 (derivative) @ $12.21 | EDGAR |
| 2026-10-30 | 4 | Woteki Catherine E — Director | Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21 | EDGAR |
| 2026-10-30 | 4 | RODRIGUEZ RAFAEL A — Director | Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21 | EDGAR |
| 2026-10-30 | 3 | Burke Kevin M — Chief HR Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-30 | 4 | Gupta Aashima — Director | Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21 | EDGAR |
| 2026-10-30 | 4 | Green Ronald D — Director | Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21 | EDGAR |
| 2026-10-30 | 4 | CAPELLO JEFFREY D — Director | Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21 | EDGAR |
| 2026-10-30 | 4 | BOREL JAMES C — Director | Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21 | EDGAR |
| 2026-10-23 | 4 | Hastings Gregory S — VP, Animal Health | Option exercise (M): 287 @ $12 · Tax withholding (F): 80 @ $12 · Option exercise (M): 287 (derivative) @ $12 | EDGAR |
| 2026-10-23 | 3 | Hastings Gregory S — VP, Animal Health | Holdings only — no transactions reported | EDGAR |
| 2026-10-21 | 3 | Walter James A — SVP of Manufacturing | Holdings only — no transactions reported | EDGAR |
| 2026-10-21 | 3 | Yarwood Jeremy — Chief Scientific Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-21 | 3 | Freels Joe B — Chief Commercial Officer | Holdings only — no transactions reported | EDGAR |
| 2026-10-09 | 4 | Nassif Mikheal — CEO, Director | Purchase (P): 505 @ $11.95 | EDGAR |
| 2026-10-02 | 4 | Woteki Catherine E — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | Wainer Andrea F — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | RODRIGUEZ RAFAEL A — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | Pelossof Avi — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | Gupta Aashima — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | Green Ronald D — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | CAPELLO JEFFREY D — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | BOREL JAMES C — Director | Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0 | EDGAR |
| 2026-08-20 | 4 | Moylan John Patrick — Chief Accounting Officer | Tax withholding (F): 2,365 @ $11.87 | EDGAR |
| 2026-08-20 | 4 | Nassif Mikheal — CEO, Director | Tax withholding (F): 20,397 @ $11.87 | EDGAR |
| 2026-08-14 | 4 | Moylan John Patrick — Chief Accounting Officer | Grant/award (A): 8,584 @ $11.65 · Grant/award (A): 18,693 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Ranalli Tamara A. — Senior Vice President | Grant/award (A): 25,751 @ $11.65 · Grant/award (A): 130,851 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Stacey Jennifer Evans — Chief Legal Officer | Grant/award (A): 38,627 @ $11.65 · Grant/award (A): 196,276 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Riggsbee Richard Bryan — CFO | Grant/award (A): 51,502 @ $11.65 · Grant/award (A): 261,702 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Nassif Mikheal — CEO, Director | Grant/award (A): 141,631 @ $11.65 · Grant/award (A): 719,679 (derivative) @ $0 | EDGAR |
| 2026-08-06 | 4 | Nassif Mikheal — CEO, Director | Purchase (P): 370 @ $11.81 | EDGAR |
| 2026-06-04 | 4 | Moylan John Patrick — Chief Accounting Officer | Tax withholding (F): 2,553 @ $8.75 | EDGAR |
| 2026-05-19 | 4 | Rocklin Amy M — Former Chief Legal Officer | Option exercise (M): 35,183 @ $9.29 · Tax withholding (F): 10,241 @ $9.29 · Option exercise (M): 35,183 (derivative) @ $9.29 | EDGAR |
| 2026-05-05 | 4 | Moylan John Patrick — Chief Accounting Officer | Option exercise (M): 4,558 @ $9.53 · Tax withholding (F): 1,568 @ $9.53 · Option exercise (M): 4,558 (derivative) @ $9.53 | EDGAR |
| 2026-05-04 | 4 | Stacey Jennifer Evans — Chief Legal Officer | Grant/award (A): 39,349 @ $9.53 · Grant/award (A): 89,520 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Nassif Mikheal — CEO, Director | Purchase (P): 23 @ $10.94 | EDGAR |
| 2026-02-02 | 4 | Nassif Mikheal — CEO, Director | Purchase (P): 25 @ $9.86 · Purchase (P): 24 @ $10.00 | EDGAR |
| 2026-01-29 | 4/A | Ranalli Tamara A. — Senior Vice President | Grant/award (A): 50,813 @ $7.38 · Grant/award (A): 50,813 @ $7.38 · Grant/award (A): 261,210 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Ranalli Tamara A. — Senior Vice President | Grant/award (A): 50,813 @ $7.38 · Grant/award (A): 130,605 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Nassif Mikheal — CEO, Director | Purchase (P): 137 @ $9.33 | EDGAR |
| 2025-12-02 | 4 | Naemura David H. — Former CFO | Option exercise (M): 12,912 @ $5.98 · Tax withholding (F): 3,548 @ $5.98 · Option exercise (M): 12,912 (derivative) @ $5.98 | EDGAR |
| 2025-11-07 | 4 | Nassif Mikheal — CEO, Director | Purchase (P): 177 @ $6.25 | EDGAR |
| 2025-11-05 | 4 | Riggsbee Richard Bryan — CFO | Grant/award (A): 178,855 @ $6.29 · Grant/award (A): 459,713 (derivative) @ $0 | EDGAR |
| 2025-10-29 | 4 | Gupta Aashima — Director | Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19 | EDGAR |
| 2025-10-29 | 4 | Green Ronald D — Director | Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19 | EDGAR |
| 2025-10-29 | 4 | BOREL JAMES C — Director | Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19 | EDGAR |
| 2025-10-29 | 4 | CAPELLO JEFFREY D — Director | Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19 | EDGAR |
| 2025-10-28 | 4 | BOEHM WILLIAM T — Director | Option exercise (M): 3,553 @ $6.07 · Option exercise (M): 3,553 (derivative) @ $6.07 | EDGAR |
| 2025-10-28 | 4 | RODRIGUEZ RAFAEL A — Director | Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19 | EDGAR |
Recent 8-K events — NEOGEN CORP
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-10-26 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-07 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
GET https://api.filingpulse.io/v1/insider-trades?ticker=NEOG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs